Edit
Bizwit-Logo-Final

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Global MicroRNA Market to reach USD 3029 million by 2027

Global MicroRNA Market Size study, by Product (Instruments, Kits & Reagent), by Application (Isolation & Purification, Detection & Quantification, Disease Diagnostics, Others), by End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Healthcare Facilities, Others) and Regional Forecasts 2020-2027

Product Code: HALB_63721290
Publish Date: 12-12-2020
Page: 200

Global MicroRNA Market is valued at approximately USD 714 million in 2019 and is anticipated to grow with a healthy growth rate of more than 19.8% over the forecast period 2020-2027. MicroRNA, or miRNA, is a minor single-trapped non-coding RNA molecule, usually found in animals, plants, and some viruses, that regulates the gene expression post-transcriptionally. miRNAs typically function through base-pairing with corresponding sequences within mRNA molecules. More often, they are well-known for their benefits in treatment and diagnosis of several diseases, including cancer, neurological disorder, infectious diseases, liver diseases, metabolic diseases, and coronary heart diseases. For example, in the case of cancer, the overexpressed miRNA are frequently studied oncogenes. Few of them are expressed in extreme low level in specific cancerous cells and typically helps in preventing tumor developments. Therefore, the high presence of cancer patients in the region driving the demand for MicroRNA market. For instance, the International Agency for Research on Cancer (IARC) found that the prevalence rate and mortality cases of cancer have been alarming in the present scenario, owing to the rapid population growth and socio-economic development. In 2018, around 18.1 million new cancer cases were reported across the world and is anticipated to reach almost 27.5 million new cancer cases by 2040. This increased prevalence of cancer and other chronic diseases may result in the high adoption of miRNA market around the world. In addition, the introduction of new RNA technology for treating genetic disorders is further fuelling the demand of overall market. For instance, in August 2018, BioNTech AG has collaborated with Pfizer to develop Messenger RNA (mRNA)-based influenza vaccines. These stimulating strategic collaborations has led to ground-breaking developments in the RNA-based therapeutics field. This, in turn, is likely to strengthen the demand for MicroRNA, globally. However, the high cost related to microRNA kits and other products, coupled with limited availability of life science infrastructure in emerging countries are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global MicroRNA market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising awareness about the benefits of MicroRNA among life science-based institutions, along with the growing number of market vendors in the region. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as growing prevalence of chronic diseases, such as cancer and cardiovascular, along with growing spending on development of biotechnology infrastructure in emerging countries, such as China and India, are the few factors creating lucrative growth opportunities for the MicroRNA market in the region.

Major market player included in this report are:
Qiagen N.V.
Thermo Fisher Scientific
BioVendor
Takara Bio Inc.
Merck KGaA
NanoString Technologies, Inc.
Heim Biotek
GeneCopoeia, Inc.
Horizon Discovery Group Co.
Synlogic, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Instruments
Reagent

By Application:
Isolation & Purification
Detection & Quantification
Disease Diagnostics
Others

By End-Use:
Pharma & Biotech Companies
Academic & Research Institutes
Healthcare Facilities
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global MicroRNA Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
1.2.1. MicroRNA Market, by Region, 2018-2027 (USD Million)
1.2.2. MicroRNA Market, by Product, 2018-2027 (USD Million)
1.2.3. MicroRNA Market, by Application, 2018-2027 (USD Million)
1.2.4. MicroRNA Market, by End-Use, 2018-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global MicroRNA Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global MicroRNA Market Dynamics
3.1. MicroRNA Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global MicroRNA Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global MicroRNA Market, by Product
5.1. Market Snapshot
5.2. Global MicroRNA Market by Product, Performance – Potential Analysis
5.3. Global MicroRNA Market Estimates & Forecasts by Product 2017-2027 (USD Million)
5.4. MicroRNA Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Kits & Reagents
Chapter 6. Global MicroRNA Market, by Application
6.1. Market Snapshot
6.2. Global MicroRNA Market by Application, Performance – Potential Analysis
6.3. Global MicroRNA Market Estimates & Forecasts by Application 2017-2027 (USD Million)
6.4. MicroRNA Market, Sub Segment Analysis
6.4.1. Isolation & Purification
6.4.2. Detection & Quantification
6.4.3. Disease Diagnostics
6.4.4. Others
Chapter 7. Global MicroRNA Market, by End-Use
7.1. Market Snapshot
7.2. Global MicroRNA Market by End-Use – Potential Analysis
7.3. Global MicroRNA Market Estimates & Forecasts by End-Use 2017-2027 (USD Million)
7.4. MicroRNA Market, Sub Segment Analysis
7.4.1. Pharma & Biotech Companies
7.4.2. Academic & Research Institutes
7.4.3. Healthcare Facilities
7.4.4. Others
Chapter 8. Global MicroRNA Market, Regional Analysis
8.1. MicroRNA Market, Regional Market Snapshot
8.2. North America MicroRNA Market
8.2.1. U.S. MicroRNA Market
8.2.1.1. Product breakdown estimates & forecasts, 2017-2027
8.2.1.2. Application breakdown estimates & forecasts, 2017-2027
8.2.1.3. End-Use breakdown estimates & forecasts, 2017-2027
8.2.2. Canada MicroRNA Market
8.3. Europe MicroRNA Market Snapshot
8.3.1. U.K. MicroRNA Market
8.3.2. Germany MicroRNA Market
8.3.3. France MicroRNA Market
8.3.4. Spain MicroRNA Market
8.3.5. Italy MicroRNA Market
8.3.6. Rest of Europe MicroRNA Market
8.4. Asia-Pacific MicroRNA Market Snapshot
8.4.1. China MicroRNA Market
8.4.2. India MicroRNA Market
8.4.3. Japan MicroRNA Market
8.4.4. Australia MicroRNA Market
8.4.5. South Korea MicroRNA Market
8.4.6. Rest of Asia Pacific MicroRNA Market
8.5. Latin America MicroRNA Market Snapshot
8.5.1. Brazil MicroRNA Market
8.5.2. Mexico MicroRNA Market
8.6. Rest of The World MicroRNA Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Qiagen N.V.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific
9.2.3. BioVendor
9.2.4. Takara Bio Inc.
9.2.5. Merck KGaA
9.2.6. NanoString Technologies, Inc.
9.2.7. Heim Biotek
9.2.8. GeneCopoeia, Inc.
9.2.9. Horizon Discovery Group Co.
9.2.10. Synlogic, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Primary Research Sources:

  • Interview conducted with raw material suppliers & manufacturers.
  • Interview conducted with manufacturers, suppliers & distributors, researchers, & representatives of regulatory bodies.
  • Interview conducted with market players, industry experts, & independent consultants.
  • Secondary Research Sources:
  • Purchased Database: D&B Hoovers, Bloomberg, Inc., Business Information Industry Association, NAICS Association.
  • Internal Database: White papers, Certified Publications, Articles by Recognized Authors and Regulatory Bodies.
  • Government Databases: Food and Agriculture Organization (FAO), European Industrial Hemp Association (EIHA), World Health Organization (WHO), Food and Drug Administration (FDA), International Telecommunication Union (ITU), United States Department of Agriculture (USDA), International organization of Motor Vehicle Manufacturers (OICA).

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now